
|
|
![]() | ![]() | ![]() | ![]() |


First Trust AMEX Biotechnology Index Fund (FBT) |



WIKI ANALYSIS| This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
First Trust AMEX Biotechnology Index Fund (FBT)
OverviewThe First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology IndexSM [1]
Fund Information
Top Holdings| Holdings | Percent (%) |
| Alexion Pharmaceuticals, Inc. | 5.54 |
| OSI Pharmaceuticals, Inc. | 5.39 |
| Cephalon, Inc. | 5.26 |
| Millipore Corporation | 5.24 |
| Human Genome Sciences, Inc. | 5.22 |
| Life Technologies Corp | 5.21 |
| Myriad Genetics, Inc. | 5.12 |
| Celgene Corporation | 5.10 |
| Gilead Sciences, Inc. | 5.04 |
| Nektar Therapeutics | 5.01 |
Holdings as of 23/10/2009
Other Bio-Technology ETFs | ETF Name | Fund Manager | Expense Ratio |
| Biotech HOLDRS ETF (BBH) | Merrill Lynch, Pierce, Fenner & Smith HOLDRS | N/A |
| First Trust AMEX Biotechnology Index Fund (FBT) | First Trust Advisors L.P | 0.60% |
| Global Biotech Portfolio ETF (PBTQ) | Invesco PowerShares | 0.75% |
| iShares Nasdaq Biotechnology Index Fund (IBB) | ishares | 0.48% |
| Powershares Dynamic Biotechnology & Genome Portfolio ETF (PBE) | Invesco PowerShares | 0.60% |
| SPDR S&P Biotech ETF (XBI) | State Street Global Markets, LLC | 0.35% |
References


| |||||||